SCHEMBL806016

SCHEMBL806016

CC(C)(Oc1ccc(NC(=O)Nc2ccc(-c3ccc(NC(=O)Nc4ccc(OC(C)(C)C(=O)O)cc4)c(Cl)c3)cc2Cl)cc1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 8/20 0.50
MEN1 O00255 5/20 0.50
KMT2A Q03164 5/20 0.50
MAPT P10636 4/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C19 P33261 1/20 0.50
NPSR1 Q6W5P4 2/20 0.47
LMNA P02545 1/20 0.47
HRH3 Q9Y5N1 1/20 0.46
PPARG P37231 2/20 0.45
FABP2 P12104 1/20 0.45
SLC22A12 Q96S37 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
GRIK1 P39086 1/20 0.44
EPHX2 P34913 1/20 0.43
IGF1R P08069 1/20 0.43
PDE5A O76074 1/20 0.42
MAP4K4 O95819 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL804706 0.92 PPARA (0.42) PPARAMEN1KMT2AMAPTCYP1A2
SCHEMBL9303086 0.90 MAPT (0.57) PPARAMEN1KMT2AMAPTCYP1A2
SCHEMBL16743448 0.89 MAPT (0.49) PPARAMEN1KMT2AMAPTCYP1A2
SCHEMBL9131125 0.88 PPARA (0.52) PPARAMEN1KMT2AMAPTCYP1A2
SCHEMBL29361873 0.87 PPARA (0.48) PPARAMEN1KMT2AMAPTCYP1A2
SCHEMBL9561356 0.85 MAPT (0.67) PPARAMEN1KMT2AMAPTCYP1A2
SCHEMBL1305388 0.84 TRPV1 (0.54) MEN1KMT2AMAPTNPSR1LMNA
SCHEMBL9303663 0.83 MEN1 (0.57) PPARAMEN1KMT2AMAPTCYP1A2
SCHEMBL16303954 0.83 PPARA (0.61) PPARAMEN1KMT2AMAPTCYP1A2
SCHEMBL805971 0.83 PPARA (0.61) PPARAMEN1KMT2AMAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9040553-B2 Phenoxyisobutyric acid compounds and method of synthesis Cell Viable Corporation (US) 2015-05-26 US disclosed
US-20140350045-A1 PHENOXYISOBUTYRIC ACID COMPOUNDS AND METHOD OF SYNTHESIS LALEZARI IRAJ (US) 2014-11-27 US disclosed
US-20120071502-A1 Novel phenoxyisobutyric acid compounds and methods for synthesis Cell Viable Corporation (US) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140350045-A1 PHENOXYISOBUTYRIC ACID COMPOUNDS AND METHOD OF SYNTHESIS AGER, BPGM, PDXK PPARA 262/4885MEN1 2478/4885KMT2A 1910/4885
US-20120071502-A1 Novel phenoxyisobutyric acid compounds and methods for synthesis AGER, BPGM, PDXK PPARA 329/4885MEN1 2627/4885KMT2A 2270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.